Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Corti

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal CancerLuca Lazzari, Giorgio Corti, Gabriele Picco, et al.
Nature Communications|December 9, 2016
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancerBeth O Van Emburgh, Sabrina Arena, Giulia Siravegna, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2012
Specific inactivation of two immunomodulatory SIGLEC genes during human evolutionXiaoxia Wang, Nivedita Mitra, Ismael Secundino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2022
Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal CancerErika Durinikova, Nicole M Reilly, Kristi Buzo, et al.
British Journal of Cancer|June 28, 2017
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancerDaniele Oddo, Giulia Siravegna, Annunziata Gloghini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal CancerSabrina Arena, Beatriz Bellosillo, Giulia Siravegna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and OxaliplatinSabrina Arena, Giorgio Corti, Erika Durinikova, et al.
Nature Communications|August 29, 2024
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patientsSimonetta M Leto, Elena Grassi, Marco Avolio, et al.
Cancer Discovery|December 9, 2015
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal CancerMariangela Russo, Giulia Siravegna, Lawrence S Blaszkowsky, et al.
Cancer Discovery|June 5, 2013
Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancerAlberto Bardelli, Simona Corso, Andrea Bertotti, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal CancerLuca Lazzari, Giorgio Corti, Gabriele Picco, et al.
Nature Communications|December 9, 2016
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancerBeth O Van Emburgh, Sabrina Arena, Giulia Siravegna, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2012
Specific inactivation of two immunomodulatory SIGLEC genes during human evolutionXiaoxia Wang, Nivedita Mitra, Ismael Secundino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2022
Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal CancerErika Durinikova, Nicole M Reilly, Kristi Buzo, et al.
British Journal of Cancer|June 28, 2017
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancerDaniele Oddo, Giulia Siravegna, Annunziata Gloghini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal CancerSabrina Arena, Beatriz Bellosillo, Giulia Siravegna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and OxaliplatinSabrina Arena, Giorgio Corti, Erika Durinikova, et al.
Nature Communications|August 29, 2024
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patientsSimonetta M Leto, Elena Grassi, Marco Avolio, et al.
Cancer Discovery|December 9, 2015
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal CancerMariangela Russo, Giulia Siravegna, Lawrence S Blaszkowsky, et al.
Cancer Discovery|June 5, 2013
Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancerAlberto Bardelli, Simona Corso, Andrea Bertotti, et al.
Pageof 5